Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep536 | Endocrine-related Cancer | ECE2020

Real medical challenges in the diagnostic of gastrinomas

Alexandra Ciobanu Oana , Tieranu Cristian , Terzea Dana , Nistor Irina , Mitrache Marius , Simona Fica

Introduction: Chronic hypergastrinemia is no longer an uncommon phenomenon. Zollinger-Ellison syndrome [ZES], chronic atrophic gastritis [CAG] type A, proton pump inhibitors [PPI] therapy, or Helicobacter pylori-induced CAG type B are causes of hypergastrinemia. Serum gastrin levels >1000 pg/ml (> 0 times the upper limit of normal) and PH gastric below 2 is the diagnostic of ZES, but two -thirds of ZES patients have serum gastrin levels below 1000 pg/ml. We present the...

ea0070aep944 | Thyroid | ECE2020

Hypercalcitonemia in a patient with micronodular goiter and adrenal nodular hyperplasia-diagnosis challenge

Nicoleta Cima Luminita , Soare Iulia , Lambrescu Ioana , Vadana Alexandra , Martin Sorina , Fica Simona

Introduction: Hypercalcitoninemia has frequently been reported as a marker for medullary thyroid carcinoma (MCT). Still, several physiologic and pathologic conditions other than MCT have been associated with increased levels of calcitonin, including neuroendocrine tumors that can ectopically secrete calcitonin.Case report: We present the case of a 78-year old female patient, incidentally diagnosed with multinodular goiter when performing Doppler ultrasou...

ea0070ep96 | Bone and Calcium | ECE2020

Epilepsy – Fahr syndrome – Primary hypoparathyroidism: A diagnostic journey

Maria Popa Miruna , Popa Liviu , Petrescu Simona , Pana Monica-Mirela , Sirbu Anca , Simona Fica

Background: Fahr syndrome is a rare entity characterized by symmetrical bilateral brain calcifications, involving basal ganglia (mainly), thalami, dentate nuclei and the cerebral and cerebellar white matter. Progressive neurologic dysfunction and other neuropsychiatric disorders are characteristic. Endocrine disorders which may present with Fahr syndrome include parathyroid dysfunction (hypoparathyroidism especially, but also pseudohypoparathyroidism, pseudopseudohypoparathyro...

ea0070ep299 | Pituitary and Neuroendocrinology | ECE2020

Non-functioning pituitary adenomas – clinical presentation and management, experience of a tertiary centre in Romania

Mustata Theodor , Martin Sorina , Mihop Delia , Predescu Andrada , Parfeni Ovidiu , Sirbu Anca , Barbu Carmen , Fica Simona

Background and Aim: Non-functioning pituitary adenomas (NFPAs) are hormonally inactive adenohypophyseal tumors. The absence of hormone hypersecretion and the lack of clinical manifestations delay the diagnosis and therefore symptoms of mass effect are frequently seen in NFPAs. The primary endpoint of this study was to evaluate the clinical presentation of patients with NFPAs and their therapeutic management. The secondary endpoint was to identify how gender and tumor size impa...

ea0070ep356 | Pituitary and Neuroendocrinology | ECE2020

Panhipopituitarism due to inoperable cavernous sinus meningioma

Andrada Predescu Florina , Mustata Theodor , Alexandru Elena , Sorina Martin Carmen , Simona Fica

Panhypopituitarism refers to decreased production of all of the pituitary hormones of the adenohypophysis with or without deficiency of neurohypophysis function. The development of the disorder is frequently insidious and the manifestations often depend on the etiology of the condition.Case report: In October 2019 a 57-year-old man collapsed in front of the hospital after being discharged from the cardiology clinic. The day before, he had undergone angio...

ea0032p348 | Diabetes | ECE2013

Long-acting insulin analogs exposure and cancer specific mortality in patients with diabetes mellitus

Ioacara Sorin , Guja Cristian , Ionescu-Tirgoviste Constantin , Fica Simona , Martin Sorina , Roden Michael

Aim: To test the hypothesis that exposure to insulin glargine might be associated with increased risk of cancer mortality compared with human basal insulin preparations.Materials and methods: All consecutive diabetes patients aged over 40 years, residing in a major urban area were screened at their first diabetes outpatient visit between 01/01/2001 and 12/31/2008 (n=79 869). Exclusion criteria were insulin treatment at screening (n=14 7...

ea0032p413 | Diabetes | ECE2013

Cardiovascular risk and prevalence of metabolic syndrome in LADA patients depending on thyroid autoimmunity presence

Reghina Aura Diana , Constantin Madalina , Georgescu Olivia , Nistor Madalina , Olaru Ramona , Florea Suzana , Fica Simona

Background: Latent autoimmune diabetes in adults (LADA) is a form of autoimmune diabetes with a slower decline of β cell function and distinct features from type 1 and type 2 diabetes. LADA is also a very heterogenic group. Frequently LADA is associated with other autoimmune diseases especially endocrine diseases.Aim: To evaluate prevalence of thyroid autoimmunity (TA) and its impact on cardiovascular risk and metabolic syndrome in LADA patients.</p...

ea0032p763 | Obesity | ECE2013

Preoperative metabolic status is associated with adiponectin levels attained 6 months after laparoscopic sleeve gastrectomy, independently of the degree of weight loss

Sirbu Anca , Martin Sorina , Barbu Carmen , Copaescu Catalin , Florea Suzana , Fica Simona

Introduction: Adiponectin is an adipocyte-derived hormone with an important role in regulation of glucose and lipid metabolism. Its variation might mediate an ameliorated metabolic profile associated with weight loss after bariatric surgery. The aim of our study was to evaluate adiponectin change as early as 6 months after laparoscopic sleeve gastrectomy (LSG) and to indicate preoperative factors that might influence its dynamic.Methods: A number of 88 e...

ea0022p777 | Thyroid | ECE2010

Simple clinical and paraclinical factors may predict outcome of treatment for Graves' hyperthyroidism

Martin Sorina , Tatucu Gheorghe Adrian , Smadeanu Elena Roxana , Florea Suzana , Fica Simona

Objective: The aim of this study was to assess the value of some clinical and paraclinical factors in an attempt to predict outcome following antithyroid drug therapy.Methodology: We performed a retrospective audit of 101 new patients, aged 16–85, separated into two groups: 59 patients with Graves’ disease (GD) and control group of 42 patients with other ethyologic forms of hyperthyroidism, admitted to our clinic between 2003 and 2008. Data wer...

ea0020p485 | Obesity and Metabolism | ECE2009

Carotid IMT values are related to insulin resistance and visceral disposition of adiposity in obese patients

Sirbu Anca , Nicolae Horia , Arbanas Tudor , Gologan Serban , Barbu Carmen , Reghina Aura , Lenghen Claudia , Fica Simona

The aim of our study was to assess the relation between common carotid intima-media thickness, a marker of subclinical atherosclerosis and other metabolic risk factors, in a group of obese patients.Patients and methods: Of 142 obese patients (47 male, 95 female, mean age 39.74±11.41 years, and mean BMI 46.88±8.85 kg/m2) were clinically and biologically evaluated. BMI and waist circumference were measured and a complete patient histor...